Directors

James Staley, Chief Executive Officer, has transferred in 164,197 shares in the company on the 16th June 2021 at a price of £0.00. The Director...

Stephen King, Chief Executive Officer, sold 72,400 shares in the company on the 16th June 2021 at a price of £0.24. The Director now holds...

Nicola Coote, Executive Director, sold 71,900 shares in the company on the 16th June 2021 at a price of £0.24. The Director now holds 2,792,013...

Shield Therapeutics, a commercial stage pharmaceutical company with a focus on tackling iron deficiency, has announced further to an initial announcement on 28 May 2021,...

London-listed investment company advised by InfraRed Capital Partners and Renewable Energy Systems, has announced the appointment of John Whittle to the board as a non-executive...

Arthur Wills, Non Executive Director, sold 5,000 shares in the company on the 15th June 2021 at a price of £3.42. The Director now holds...

Christiaan van der Kuyl, Chairman, bought 20,000 shares in the company on the 17th June 2021 at a price of £1.81. The Director now holds...

Michael Butterworth, Non Executive Director, bought 30,800 shares in the company on the 17th June 2021 at a price of £0.97. The Director now holds...

Richard Briere, Financial Director, bought 10,000 shares in the company on the 17th June 2021 at a price of £0.53. The Director now holds 135,000...

Alison Baker, Non Executive Director, bought 5,856 shares in the company on the 16th June 2021 at a price of £1.66. The Director now holds...